Healthcare Press

SA, Uganda Bi-annual HIV Prevention Injection Prevents Infection in Young Women, SA Enthused: “Good”

  • 📰 brieflyza
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 68%

SA Government News

Health Health Latest News,Health Health Headlines

A new HIV trial involving 5000 participants in South Africa and Uganda has proven effective in preventing new infections in vulnerable young women aged 16 to 25.

The study involved a sample size of 5000 participants at 25 sites in South Africa and three in Uganda

It interferes with the HIV capsid, a protein shell that protects HIV’s genetic material and enzymes needed for replication. The first was whether lenacapavir was safe and would provide better protection for women aged 16 to 25 than Truvada F/TDF, a widely used daily PrEP.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 10. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Twice-yearly HIV prevention shot succeeds in pivotal trial: questions now loom over accessTwice-yearly HIV prevention shot succeeds in pivotal trial: questions now loom over access
Source: News24 - 🏆 4. / 80 Read more »